Tai-Chung Huang

11PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyMedical virologyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Dec 18, 2025
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma.

Yu-Sung Chang, Wan-Chen Hsieh, Hsueh-Mei Chang

|Dec 09, 2025
Time to progression is a simple and robust prognostic factor for survival in relapsed or refractory diffuse large B-cell lymphoma.

Chieh-Lung Cheng, Tai-Chung Huang, Yu-Hsuan Tuan

|Apr 11, 2025
Impact of Comorbidities on Patients With Waldenström Macroglobulinemia in Taiwan: A Multicenter Study.

Yu-Sung Chang, Yu-Hsuan Tuan, Jun-Wei Gao

|Dec 03, 2024
Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA.

Hsin-Hsien Lin, I-Shing Yu, Ming-Shan Cheng

|Nov 06, 2024
Preliminary assessment of the accuracy of cutaneous T-cell lymphoma diagnosis through deep sequencing of the TRG gene.

Jin-Bon Hong, Tyng-Shiuan Hsieh, Tsen-Fang Tsai

Pageof 2

Frequent Collaborators

2 joint publications

Yu-Sung Chang

1 joint publications

Yu-Hung Wang

1 joint publications

Cheng-Hong Tsai

1 joint publications

Yuan-Yeh Kuo